
Episode 2: Building on Amyloid Lowering: Key Insights from Recent Data and Prospects for Complementary Therapeutic Approaches
Featuring:
Anthony Caggiano, M.D., Ph.D., Chief Medical Officer and Head of R&D, Cognition Therapeutics
Christopher H. van Dyck, M.D., Yale University School of Medicine, Professor of Psychiatry, Neurology, and Neuroscience
Director of the Division of Aging and Geriatric Psychiatry; Director of the Alzheimer’s Disease Research Center
Anton P. Porsteinsson, M.D., University of Rochester School of Medicine and Dentistry, William B. and Sheila Konar Professor of Psychiatry, Neurology, Neuroscience, and Medicine
Director of the Alzheimer’s Disease Care, Research and Education Program (AD-CARE)
Index:
0:00 Introduction
1:47 Reactions to lecanemab results
3:48 Impact of targeting plaque
6:46 Potentially complementary strategies
11:24 Future of Alzheimer’s therapies
13:40 Conclusion
Flere episoder fra "Cognition Conversations"



Gå ikke glip af nogen episoder af “Cognition Conversations” - abonnér på podcasten med gratisapp GetPodcast.








